Evidence map›Paper›PMID 37508513›Full record

ArticleCells2023

Mathematical Modeling of Clonal Interference by Density-Dependent Selection in Heterogeneous Cancer Cell Lines.

Thomas Veith, Andrew Schultz, Saeed Alahmari, Richard Beck, Joseph Johnson, Noemi Andor

Abstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thomas VeithMoffitt Cancer Center, Integrated Mathematical Oncology, USF Magnolia Drive, Tampa, FL 33612, USA.ORCID 0000-0001-8411-9911
Andrew SchultzMoffitt Cancer Center, Integrated Mathematical Oncology, USF Magnolia Drive, Tampa, FL 33612, USA.
Saeed AlahmariDepartment of Computer Science, Najran University, King Abdulaziz Road, Najran 61441, Saudi Arabia.
Richard BeckMoffitt Cancer Center, Integrated Mathematical Oncology, USF Magnolia Drive, Tampa, FL 33612, USA.
Joseph JohnsonMoffitt Cancer Center, Analytic Microscopy Core, USF Magnolia Drive, Tampa, FL 33612, USA.
Noemi AndorMoffitt Cancer Center, Integrated Mathematical Oncology, USF Magnolia Drive, Tampa, FL 33612, USA.

Funding

Characterizing cytotoxic therapy induced shifts in the cost-to-benefit ratio of high ploidyR37CA266727 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI Noemi Andor · 2022 to 2026
$2.6M
IMAT-ITCR Collaboration: Engineering model-based systems to monitor and steer subclonal dynamicsR21CA269415 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI ANDOR, NOEMI · 2023 to 2024
$499k
NCI NIH HHS R21 CA269415NCI NIH HHS R37 CA266727NIH HHS 1R37CA266727-01A1
6 · The paper itself

Abstract

Many cancer cell lines are aneuploid and heterogeneous, with multiple karyotypes co-existing within the same cell line. Karyotype heterogeneity has been shown to manifest phenotypically, thus affecting how cells respond to drugs or to minor differences in culture media. Knowing how to interpret karyotype heterogeneity phenotypically would give insights into cellular phenotypes before they unfold temporally. Here, we re-analyzed single cell RNA (scRNA) and scDNA sequencing data from eight stomach cancer cell lines by placing gene expression programs into a phenotypic context. Using live cell imaging, we quantified differences in the growth rate and contact inhibition between the eight cell lines and used these differences to prioritize the transcriptomic biomarkers of the growth rate and carrying capacity. Using these biomarkers, we found significant differences in the predicted growth rate or carrying capacity between multiple karyotypes detected within the same cell line. We used these predictions to simulate how the clonal composition of a cell line would change depending on density conditions during

Indexed as

NeoplasmsCell LineClone CellsHumansKaryotypeKaryotypingdensity-dependent selectionintratumoral heterogeneitylife history theorymathematical oncologyr/K selectiontumor evolution

Identifiers

PMID37508513
PMCPMC10378185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.